Hi everybody,
thank you for the discussion. To me: diagnosed with ovarian clear cell OCCC in Feb 2023 stage IV. Good complete surgery and 6 cycles of Carbo+Paclitaxel (Standard) + Avastin. Avastin for total of 12 cycles. Small splenic recurrence seen on CT in February. I am not classic OCCC as my genetic show that I am TP53 positive. They categorize me as Carbo platin sensitive, but recurrence was after 7 months - so barely sensitive. Trial that was offered in Buffalo was Pembrolizumab (PD-1 antagonist, immune therapy) + immune enhancer _+ Avastin. Made sense to me. Also understand that cancer is a systemic disease (book "Emperor of all maladies"). But caveat was that participation not before August and inclusion in trial is not guaranteed. I actually now learn that getting on a clinical trial is actually really difficult. Also self-costs would be $12-13,000 per cycle or $255,000/year or CAN$ 355,000/year. On the other hand, my oncologist here (PMH) gave me the chance for 2nd surgery and I am going for it tomorrow.
I am a scientist myself and dived into ovarian cancer research - like most of you. There is not much out there for clear cell. It behaves differently compared to serous cell. It does not well respond to carboplatin and associated drugs, PARP inhibitors don't work but may respond better to immune therapy. Most of the clinical trials include serous cell but not clear cells. There is a very limited number of clinical trials in Canada. This because a) smaller country and b) more restriction from Health Canada. Yes, we need to advocate, and I am so happy to see that you are all doing this already. If you look for clinical trials: go to
https://ocra.careboxhealth.com/
this is a site from the Ovarian cancer research alliance (US based) or go to
https://clinicaltrials.gov/
- all clinical trials need to be registered on this site. You can type your cancer in there. There is an email contact for each clinical trial.
talk to you soon agin.